参考文献/References:
1 Walter FM, Rubin G, Bankhead C, et al. Symptoms and other
factors associated with time to diagnosis and stage of lung cancer: a
prospective cohort study [J]. Br J Cancer, 2015, 112(Suppl 1): S6-S13.
2 Li H, Fan X, Houghton J. 2007. Tumor microenvironment: The role of
the tumor stroma in cancer [J]. J Cell Biochem,2007,101: 805-815.
3 Hall B, Andreeff M, Marini F. The participation of mesenchymal stem
cells in tumor stroma formation and their application as targeted-gene
delivery vehicles. Handb Exp Pharmacol 2007: 263-283.
4 Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate
allogeneic immune cell responses [J]. Blood, 2005, 105(4): 1815-1822.
5 Ringdén O, Uzunel M, Rasmusson I, et al. Mesenchymal stem
cells for treatment of therapy-resistant graft-versus-host disease [J].
Transplantation, 2006, 81(10): 1390-1397.
6 Zhu W, Xu W, Jiang R, et al. Mesenchymal stem cells derived from
bone marrow favor tumor cell growth in vivo [J]. Exp Mol Pathol,
2006, 80(3): 267-274.
7 Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of
fibroblast colonies in monolayer cultures of guinea-pig bone marrow
and spleen cells [J]. Cell Tissue Kinet, 1970, 3(4): 393-403.
8 Caterson EJ, Nesti LJ, Danielson KG, et al. Human marrow-derived
mesenchymal progenitor cells: isolation, culture expansion, and
analysis of differentiation [J]. Mol Biotechnol, 2002, 20(3): 245-256.
9 Martin DR, Cox NR, Hathcock TL, et al. Isolation and characterization
of multipotential mesenchymal stem cells from feline bone marrow [J].
Exp Hematol, 2002, 30(8): 879-886.
10 Kadiyala S, Young RG, Thiede MA, et al. Culture expanded canine
mesenchymal stem cells possess osteochondrogenic potential in vivo
and in vitro [J]. Cell Transplant, 1997, 6(2): 125-134.
11 Lennon DP, Caplan AI. Isolation of rat marrow-derived mesenchymal
stem cells [J]. Exp Hematol, 2006, 34(11): 1606-1607.
12 Jessop HL, Noble BS, Cryer A. The differentiation of a potential
mesenchymal stem cell population within ovine bone marrow [J].
Biochem Soc Trans, 1994, 22(3): 248S.
13 Izadpanah R, Joswig T, Tsien F, et al. Characterization of multipotent
mesenchymal stem cells from the bone marrow of rhesus macaques [J].
Stem Cells Dev, 2005, 14(4): 440-451.
14 Tolar J, Nauta AJ, Osborn MJ, et al. Sarcoma derived from cultured
mesenchymal stem cells [J]. Stem Cells, 2007, 25(2): 371-379.
15 Aguilar S, Nye E, Chan J, et al. Murine but not human mesenchymal
stem cells generate osteosarcoma-like lesions in the lung [J]. Stem
Cells, 2007, 25(6):1586-94.
16 Li H, Fan X, Kovi RC, et al. Spontaneous expression of embryonic
factors and p53 point mutations in aged mesenchymal stem cells: a
model of age-related tumorigenesis in mice [J]. Cancer Res, 2007,
67(22): 10889-10898.
17 Xu S, De Becker A, De Raeve H, et al. In vitro expanded bone
marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells
can acquire CD34 expression and induce sarcoma formation in vivo [J].
Biochem Biophys Res Commun, 2012, 424(3): 391-397.
18 Eslaminejad MB, Nikmahzar A, Taghiyar L, et al. Murine
mesenchymal stem cells isolated by low density primary culture
system [J]. Dev Growth Differ, 2006, 48(6): 361-370.
19 Soleimani M, Nadri S. A protocol for isolation and culture of
mesenchymal stem cells from mouse bone marrow [J]. Nat Protoc,
2009, 4(1): 102-106.
20 Nadri S, Soleimani M. Isolation murine mesenchymal stem cells by
positive selection [J]. In Vitro Cell Dev Biol Anim, 2007, 43(8/9): 276-
282.
21 Kopen GC,Prockop DJ,Phinney DG.marrow stromal cells migrate
throughout forebrain and cerebellum,and they differentiate into
astrocytes after injection into neonatal mouse brains [J]. Proc Natl
Acad Sci U S A, 1999, 96(19): 10711-10716.
22 Baddoo M, Hill K, Wilkinson R, et al. Characterization of
mesenchymal stem cells isolated from murine bone marrow by
negative selection [J]. J Cell Biochem, 2003, 89(6): 1235-1249.
23 Eslaminejad MB, Nadri S. Murine mesenchymal stem cell isolated
and expanded in low and high density culture system: surface antigen
expression and osteogenic culture mineralization [J]. In Vitro Cell Dev
Biol Anim, 2009, 45(8): 451-459.
24 Morikawa S, Mabuchi Y, Kubota Y, et al. Prospective identification,
isolation, and systemic transplantation of multipotent mesenchymal
stem cells in murine bone marrow [J]. J Exp Med, 2009, 206(11):
2483-2496.
25 Short BJ, Brouard N, Simmons PJ. Prospective isolation of
mesenchymal stem cells from mouse compact bone [J]. Methods Mol
Biol, 2009, 482: 259-268.
26 Xu S, De Becker A, Van Camp B, et al. An improved harvest
and in vitro expansion protocol for murine bone marrow-derived
mesenchymal stem cells [J]. J Biomed Biotechnol. 2010:105940.
27 Zhang MH, Hu YD, Xu Y, et al. Human mesenchymal stem cells
enhance autophagy of lung carcinoma cells against apoptosis during
serum deprivation [J]. Int J Oncol, 2013, 42(4): 1390-1398.
28 Suzuki K, Sun R, Origuchi M, et al. Mesenchymal stromal cells
promote tumor growth through the enhancement of neovascularization
[J]. Mol Med, 2011, 17(7/8): 579-587.
29 Block GJ, Ohkouchi S, Fung F, et al. Multipotent stromal cells are
activated to reduce apoptosis in part by upregulation and secretion of
stanniocalcin-1 [J]. Stem Cells, 2009, 27(3): 670-681.
30 Zhang Y, Daquinag A, Traktuev DO, et al. White adipose tissue cells
are recruited by experimental tumors and promote cancer progression
in mouse models [J]. Cancer Res, 2009, 69(12): 5259-5266.
31 Jeon ES, Lee IH, Heo SC, et al. Mesenchymal stem cells stimulate
angiogenesis in a murine xenograft model of A549 human
adenocarcinoma through an LPA1 receptor-dependent mechanism [J].
Biochim Biophys Acta, 2010, 1801(11): 1205-1213.
32 Tian LL, Yue W, Zhu F, et al. Human mesenchymal stem cells play a
dual role on tumor cell growth in vitro and in vivo [J]. J Cell Physiol,
2011, 226(7): 1860-1867.
33 Li L, Tian H, Chen Z, et al. Inhibition of lung cancer cell proliferation
mediated by human mesenchymal stem cells [J]. Acta Biochim
Biophys Sin (Shanghai), 2011, 43(2): 143-148.
34 Kéramidas M, De Fraipont F, Karageorgis A, et al. The dual effect of
mesenchymal stem cells on tumour growth and tumour angiogenesis
[J]. Stem Cell Res Ther, 2013, 4(2): 41.
·58· 中华老年骨科与康复电子杂志 2015 年 11月 第 1 卷 第 2 期 Chin J Geriatr Orthop Rehabil (Electronic Edition), November 2015, Vol.1, No.2
35 Bremnes RM, D?nnem T, Al-Saad S, et al. The role of tumor stroma in
cancer progression and prognosis: emphasis on carcinoma-associated
fibroblasts and non-small cell lung cancer [J]. J Thorac Oncol, 2011,
6(1): 209-217.
36 Do EK, Kim YM, Heo SC, et al. Lysophosphatidic acid-induced
Adam12 expression mediates human adipose tissue-derived
mesenchymal stem cell-stimulated tumor growth [J]. Int J Biochem
Cell Biol, 2012, 44(11): 2069-2076.
37 Jacobsen J, Wewer UM.Targeting ADAM12 in human disease: head,
body or tail [J]. Curr Pharm Des,2009,15(20):2300-2310.
38 Mino N, Miyahara R, Nakayama E, et al. A disintegrin and
metalloprotease 12 (Adam12) is a prognostic factor in resected
pathological stage I lung adenocarcinoma [J]. J Surg Oncol, 2009,
100(3): 267-272.
39 Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid
in cancer [J]. Nat Rev Cancer, 2003, 3(8): 582-591.
40 Jeon ES, Moon HJ, Lee MJ, et al. Cancer-derived lysophosphatidic
acid stimulates differentiation of human mesenchymal stem cells to
myofibroblast-like cells [J]. Stem Cells, 2008, 26(3): 789-797.
41 Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to
organ-specific colonization [J]. Nat Rev Cancer, 2009, 9(4): 274-284.
42 Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and
evolving paradigms [J]. Cell, 2011, 147(2): 275-292.
43 Xu MH, Gao X, Luo D, et al. EMT and acquisition of stem celllike
properties are involved in spontaneous formation of tumorigenic
hybrids between lung cancer and bone marrow-derived mesenchymal
stem cells [J]. PLoS One, 2014, 9(2): e87893.
44 Choe C, Shin YS, Kim SH, et al. Tumor-stromal interactions with
direct cell contacts enhance motility of non-small cell lung cancer
cells through the hedgehog signaling pathway [J]. Anticancer Res,
2013, 33(9): 3715-3723.
45 Guan J, Chen J. Mesenchymal s tem cells i n the tumor
microenvironment [J]. Biomed Rep, 2013, 1(4): 517-521.
46 Konopleva M, Konoplev S, Hu W, et al. Stromal cells prevent
apoptosis of AML cells by up-regulation of anti-apoptotic proteins [J].
Leukemia, 2002, 16(9): 1713-1724.
47 Bergfeld SA, Blavier L, Declerck YA. Bone marrow-derived
mesenchymal stromal cells promote survival and drug resistance in
tumor cells [J]. Mol Cancer Ther, 2014, 13(4): 962-975.
48 Roodhart JM, Daenen LG, Stigter EC, et al. Mesenchymal stem cells
induce resistance to chemotherapy through the release of platinuminduced
fatty acids [J]. Cancer Cell, 2011, 20(3): 370-383.
49 Mink SR, Vashistha S, Zhang W, et al. Cancer-associated fibroblasts
derived from EGFR-TKI-resistant tumors reverse EGFR pathway
inhibition by EGFR-TKIs [J]. Mol Cancer Res, 2010, 8(6): 809-820.
50 Oyewumi MO, Alazizi A, Wehrung D, et al. Emerging lung cancer
therapeutic targets based on the pathogenesis of bone metastases [J].
Int J Cell Biol, 2014: 236246.
51 Giuliani N, Morandi F, Tagliaferri S, et al. Production of Wnt inhibitors
by myeloma cells: potential effects on canonical Wnt pathway in the
bone microenvironment [J]. Cancer Res, 2007, 67(16): 7665-7674.
52 Fernández Vallone VB, Hofer EL, Choi H, et al. Behaviour of
mesenchymal stem cells from bone marrow of untreated advanced
breast and lung cancer patients without bone osteolytic metastasis [J].
Clin Exp Metastasis, 2013, 30(3): 317-332.
53 Song Xu, Yi Wu, Renwang Liu, et al. Serum microRNA-139-5p is
a biomarker of bone metastasis in lung cancer patient [J]. J Thorac
Oncol, 2015,10(2): S389.